Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
Baxter
McKesson
Citi
Julphar
US Army
Merck
Argus Health

Generated: September 23, 2018

DrugPatentWatch Database Preview

Drugs in MeSH Category Ganglionic Blockers

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nexgen Pharma MECAMYLAMINE HYDROCHLORIDE mecamylamine hydrochloride TABLET;ORAL 204054-001 Mar 19, 2013 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Targacept INVERSINE mecamylamine hydrochloride TABLET;ORAL 010251-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche ARFONAD trimethaphan camsylate INJECTABLE;INJECTION 008983-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Ayerst ANSOLYSEN pentolinium tartrate INJECTABLE;INJECTION 009372-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cerilliant
Dow
Accenture
Moodys
Teva
AstraZeneca
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.